Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Thalassemia in europe: A cross-border real-world data analysis from the radeep registry

Blood (2025) 146 (Supplement 1): 4696.

https://doi.org/10.1182/blood-2025-4696

Published: 2025

Journal Articles

Disease monitoring and management among pediatric patients with pyruvate kinase deficiency: Real-world practices from pyruvate kinase deficiency registries prior to 2024 international expert guidelines

Sule Unal, Stefan W. Eber, Andreas Glenthoej, Bertil Glader, Eduard Van Beers, Rachael Grace, Joan-Lluis Vives Corrons, Hitoshi Kanno, Kevin Kuo, Paola Bianchi, Bryan McGee, Yan (Flame) Yan, Audra Boscoe, Junlong Li, Janet Ford, Carl Lander

Blood (2025) 146 (Supplement 1): 4454.

https://doi.org/10.1182/blood-2025-4454

Published: 2025

Journal Articles

Sickle cell disease in europe: A cross-border real-world data analysis from the radeep registry

Blood (2025) 146 (Supplement 1): 179.

https://doi.org/10.1182/blood-2025-179

Published: 2025

Journal Articles

No overall increased risk of death or cardiovascular disease in individuals with sickle cell trait: A prospective study of 467,957 general population adults

Marie Warny, Jens Helby, Shoaib Afzal, Shaodong Wei, Jesper Petersen, Andreas Glenthoej

Blood (2025) 146 (Supplement 1): 4440.

https://doi.org/10.1182/blood-2025-4440

Published: 2025

Journal Articles

Risk of death and comorbidities in β-thalassemia carriers identified by consecutive genotyping: A prospective cohort study of 467,242 general population individuals

Lilla Gaál, Marie Warny, Jesper Petersen, Shoaib Afzal, Jens Helby, Andreas Glenthoej

Blood (2025) 146 (Supplement 1): 2661.

https://doi.org/10.1182/blood-2025-2661

Published: 2025

Journal Articles

RP-L301, a Lentiviral-Mediated Gene Therapy for Pyruvate Kinase Deficiency (PKD): A Phase 2 Clinical Trial Design

Blood (2024) 144 (Supplement 1): 3583.1.

https://doi.org/10.1182/blood-2024-201734

Published: 2024

Journal Articles

Risk of Fractures in Individuals with Hemochromatosis HFE C282Y Homozygosity and in Individuals with Low or High Levels of Plasma Iron, Transferrin Saturation, or Ferritin: A Prospective Study of 142,146 General Population Individuals

Jens Helby, Marie Warny, Stig Egil Bojesen, Boerge Groenne Nordestgaard, Jesper Petersen, Christina Ellervik, Andreas Glenthoej

Blood (2024) 144 (Supplement 1): 1087.

https://doi.org/10.1182/blood-2024-202616

Published: 2024

Journal Articles

Absolute Risk of Multiple Myeloma Is Quite Modest in Individuals with Incidentally Discovered Vertebral Fractures: A Prospective Cohort Study of 9,065 CT-Scanned Danish General Population Individuals with Independent Validation in a UK General Population Cohort

Rasmus Rønnemoes, Anne Rudbeck Juhl, Shoaib Afzal, Stig Egil Bojesen, Boerge Groenne Nordestgaard, Michael Huy Cuong Pham, Klaus Fuglsang Kofoed, Jørgen Tobias Kühl, Andreas Fuchs, Per Ejlstrup Sigvardsen, Thomas S. Kristensen, Jesper Petersen, Andreas Glenthoej, Jens Helby

Blood (2024) 144 (Supplement 1): 3334.

https://doi.org/10.1182/blood-2024-193953

Published: 2024

Journal Articles

Analysis of the Pilot Study of the International Hemoglobinopathy Research Network (INHERENT)

Blood (2024) 144 (Supplement 1): 1132.

https://doi.org/10.1182/blood-2024-200469

Published: 2024

Journal Articles

uRADAR: European Patients Referral Frame to Improve Access to New Drugs and Therapies in Ultra-Rare Anemia Disorders and Severe Hereditary Spherocytosis

Blood (2024) 144 (Supplement 1): 794.

https://doi.org/10.1182/blood-2024-201501

Published: 2024

Journal Articles

Absolute and Relative Risks of Hematologic Disease and Cause-Specific Death in Individuals with Incidentally Discovered Thrombocytopenia: A Prospective Study of Two Independent General Population Cohorts Including 486,782 Individuals from the United Kingdom and Denmark

Anne Rudbeck Juhl, Andreas Glenthoej, Boerge Groenne Nordestgaard, Jesper Petersen, Morten Dahl, Christina Ellervik, Stig Egil Bojesen, Jens Helby

Blood (2023) 142 (Supplement 1): 395.

https://doi.org/10.1182/blood-2023-173792

Published: 2023

Journal Articles

Regional Genetic Heterogeneity Among Patients with Pyruvate Kinase Deficiency

Paola Bianchi, Elisa Fermo, Kevin H.M. Kuo, Dagmar Pospíšilová, Andreas Glenthoej, Carl Lander, Eduard J. Van Beers, Bertil Glader, Joan-Lluis Vives Corrons, Stefan W Eber, Yan Yan, Bryan McGee, Janet H Ford, Saliha Yilmaz, Rachael F. Grace

Blood (2023) 142 (Supplement 1): 5203.

https://doi.org/10.1182/blood-2023-181834

Published: 2023

Journal Articles

Is Epigenetic Modulation to Induce Fetal Hemoglobin Translatable in Sickle Cell Mice?

Ariadna Carol Illa, Jesper Petersen, Søren Skov, Andreas Glenthoej, Carsten Dan Ley

Blood (2023) 142 (Supplement 1): 5261.

https://doi.org/10.1182/blood-2023-173922

Published: 2023

Journal Articles

Decoding the Historical TALE: COVID-19 Impact on Hematological Malignancy Patients - Insights from 2020 to 2022

Francesco Marchesi, Jon Salmanton-García, Francesca Farina, Barbora Weinbergerova, Federico Itri, Julio Dávila-Valls, Sonia Martín-Pérez, Andreas Glenthoej, Ditte Hersby, Maria Gomes Da Silva, Raquel Nunes-Rodrigues, Raul Cordoba, Alberto Lopez Garcia, Ziad Emarah, Shaimaa El-Ashwah, Yavuz M. Bilgin, Laman Rahimli, Oliver Cornely, Livio Pagano

Blood (2023) 142 (Supplement 1): 1067.

https://doi.org/10.1182/blood-2023-188942

Published: 2023

Journal Articles

Safety and Efficacy of Mitapivat in Adult Patients with Erythrocyte Membranopathies (SATISFY)

Andreas Glenthoej, Eduard J. Van Beers, Richard van Wijk, Minke A.E. Rab, Evelyn Groot, Niels G Vejlstrup, Selma K Bendtsen, Nina Toft, Jesper Petersen, Jens Helby, Fatiha Chermat, Pierre Fenaux, Kevin H.M. Kuo

Blood (2023) 142 (Supplement 1): 1085.

https://doi.org/10.1182/blood-2023-173147

Published: 2023

Journal Articles

Clinical Outcome of Covid-19 in Haematologic Malignancy Patients with a Fourth Dose of Anti-Sars-Cov-2 Vaccine: A Final Epicovideha Report

Meinolf Karthaus, Jon Salmanton-García, Francesco Marchesi, Andreas Glenthoej, Yavuz M Bilgin, Jens Van Praet, Laman Rahimli, Oliver Cornely, Livio Pagano

Blood (2023) 142 (Supplement 1): 7262.

https://doi.org/10.1182/blood-2023-189041

Published: 2023

Journal Articles

Mitapivat Improves Ineffective Erythropoiesis and Reduces Iron Overload in Patients with Pyruvate Kinase Deficiency

Eduard J. Van Beers, Hanny Al-Samkari, Rachael F. Grace, Wilma Barcellini, Andreas Glenthoej, Malia P. Judge, Penelope A. Kosinski, Emily Xu, Vanessa Beynon, Bryan McGee, John B. Porter, Kevin H.M. Kuo

Blood (2021) 138 (Supplement 1): 2005.

https://doi.org/10.1182/blood-2021-147317

Published: 2021

Journal Articles

Bone Mineral Density Remains Stable in Pyruvate Kinase Deficiency Patients Receiving Long-Term Treatment with Mitapivat

Hanny Al-Samkari, Rachael F. Grace, Andreas Glenthoej, Oliver Andres, Wilma Barcellini, Frédéric Galactéros, Kevin H.M. Kuo, D. Mark Layton, Marta Morado, Vip Viprakasit, Yan Dong, Feng Tai, Liz Grekas, Karishma Khoja, Sarah Gheuens, Bryan McGee, John B. Porter, Eduard J. Van Beers

Blood (2021) 138 (Supplement 1): 924.

https://doi.org/10.1182/blood-2021-147156

Published: 2021

Journal Articles

COVID-19 Infection in Vaccinated Adult Patients with Hematological Malignancies. Preliminary Results from Epicovideha (Epidemiology of COVID-19 infection in patients with hematological malignancies: A European Haematology Association Survey)

Francesco Marchesi, Jon Salmanton-García, Alberto Lopez-Garcia, Giulia Dragonetti, Uluhan Sili, Andreas Glenthoej, Caterina Buquicchio, Malgorzata Mikulska, Barbora Weinbergerova, Alessandro Busca, Paolo Corradini, Martin Hoenigl, Nikolay N. Klimko, Antonio Pagliuca, Francesco Passamonti, Philipp Köhler, Oliver Cornely, Livio Pagano

Blood (2021) 138 (Supplement 1): 3733.

https://doi.org/10.1182/blood-2021-147295

Published: 2021

Journal Articles

Durability of Hemoglobin Response and Reduction in Transfusion Burden Is Maintained over Time in Patients with Pyruvate Kinase Deficiency Treated with Mitapivat in a Long-Term Extension Study

Blood (2021) 138 (Supplement 1): 848.

https://doi.org/10.1182/blood-2021-147711

Published: 2021

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Thalassemia in europe: A cross-border real-world data analysis from the radeep registry

Disease monitoring and management among pediatric patients with pyruvate kinase deficiency: Real-world practices from pyruvate kinase deficiency registries prior to 2024 international expert guidelines

Sickle cell disease in europe: A cross-border real-world data analysis from the radeep registry

No overall increased risk of death or cardiovascular disease in individuals with sickle cell trait: A prospective study of 467,957 general population adults

Risk of death and comorbidities in β-thalassemia carriers identified by consecutive genotyping: A prospective cohort study of 467,242 general population individuals

RP-L301, a Lentiviral-Mediated Gene Therapy for Pyruvate Kinase Deficiency (PKD): A Phase 2 Clinical Trial Design

Risk of Fractures in Individuals with Hemochromatosis HFE C282Y Homozygosity and in Individuals with Low or High Levels of Plasma Iron, Transferrin Saturation, or Ferritin: A Prospective Study of 142,146 General Population Individuals

Absolute Risk of Multiple Myeloma Is Quite Modest in Individuals with Incidentally Discovered Vertebral Fractures: A Prospective Cohort Study of 9,065 CT-Scanned Danish General Population Individuals with Independent Validation in a UK General Population Cohort

Analysis of the Pilot Study of the International Hemoglobinopathy Research Network (INHERENT)

uRADAR: European Patients Referral Frame to Improve Access to New Drugs and Therapies in Ultra-Rare Anemia Disorders and Severe Hereditary Spherocytosis

Absolute and Relative Risks of Hematologic Disease and Cause-Specific Death in Individuals with Incidentally Discovered Thrombocytopenia: A Prospective Study of Two Independent General Population Cohorts Including 486,782 Individuals from the United Kingdom and Denmark

Regional Genetic Heterogeneity Among Patients with Pyruvate Kinase Deficiency

Is Epigenetic Modulation to Induce Fetal Hemoglobin Translatable in Sickle Cell Mice?

Decoding the Historical TALE: COVID-19 Impact on Hematological Malignancy Patients - Insights from 2020 to 2022

Safety and Efficacy of Mitapivat in Adult Patients with Erythrocyte Membranopathies (SATISFY)

Clinical Outcome of Covid-19 in Haematologic Malignancy Patients with a Fourth Dose of Anti-Sars-Cov-2 Vaccine: A Final Epicovideha Report

Mitapivat Improves Ineffective Erythropoiesis and Reduces Iron Overload in Patients with Pyruvate Kinase Deficiency

Bone Mineral Density Remains Stable in Pyruvate Kinase Deficiency Patients Receiving Long-Term Treatment with Mitapivat

COVID-19 Infection in Vaccinated Adult Patients with Hematological Malignancies. Preliminary Results from Epicovideha (Epidemiology of COVID-19 infection in patients with hematological malignancies: A European Haematology Association Survey)

Durability of Hemoglobin Response and Reduction in Transfusion Burden Is Maintained over Time in Patients with Pyruvate Kinase Deficiency Treated with Mitapivat in a Long-Term Extension Study

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only